(Q35652505)

9 August 2017

1 reference

title

Role for osteoprotegerin in rheumatoid inflammation (English)

1 reference

9 August 2017

Nathalie Saidenberg-Kermanac'h

1

1 reference

9 August 2017

Martine Cohen-Solal

2

1 reference

9 August 2017

Natacha Bessis

3

1 reference

9 August 2017

Marie-Christine De Vernejoul

4

1 reference

9 August 2017

Marie-Christophe Boissier

5

1 reference

9 August 2017

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

71

1 reference

9 August 2017

9-13

1 reference

9 August 2017

1

1 reference

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

TRANCE is a TNF family member that regulates dendritic cell and osteoclast function

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Activated T lymphocytes support osteoclast formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Erratum: Colour categories in a stone-age tribe

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Interleukin 4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Pathogenesis of bone erosions in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

The effect of a single dose of osteoprotegerin in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion

1 reference

https://api.crossref.org/works/10.1016%2FS1297-319X%2803%2900131-3

7 January 2021

10.1016/S1297-319X(03)00131-3

Identifiers

DOI

1 reference

9 August 2017

1 reference